The global swine vaccines market has grown strongly in recent years. It will grow from $2.01 billion in 2023 to $2.20 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The global swine vaccines market is expected to see strong growth in the next few years. It will grow to $3.17 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%.
The growth observed during the historical period can be attributed to several factors, including disease outbreaks that affected swine populations, resulting in significant economic losses within the industry. Additionally, government regulations aimed at managing and controlling these outbreaks also influenced growth, alongside an overall increase in swine production.
Anticipated growth in the forecast period can be linked to several key factors, including the emergence of new diseases and viral strains affecting swine, the increasing globalization of the swine industry, changes in climate and environmental conditions, the implementation of stringent biosecurity measures, and intensified market competition within the industry. Key trends expected in the forecast period encompass advancements in veterinary science, shifts in disease patterns, a global surge in demand for protein sources, ongoing technological advancements in the field, and a heightened focus on preventive healthcare strategies for swine.
The escalating incidence of diseases in swine is anticipated to drive growth in the swine vaccine market. Swine diseases, characterized by deviations from normal structural or functional conditions and exhibiting signs such as pseudorabies and influenza, necessitate the use of vaccines to protect pigs from infectious diseases.
Market Dynamics and Regional Insights
The prominence of North America in the swine vaccines market, coupled with the anticipated rapid progression of Asia-Pacific regions, signals a wider global trend towards ensuring the health and productivity of pig populations. The widespread consumption of pork and the associated demand for assurances of safety and quality underscore the urgency of effective vaccine implementation.
Key market trends include the advent of TwistPak technology, offering streamlined vaccination solutions, and the innovative 3-in-one Circumvent CML vaccine. These advances demonstrate the market’s dedication to improved efficacy and convenience in swine herd management.
Noteworthy Market Developments
The advancements in the swine vaccines market are underscored by strategic initiatives such as the acquisition of Newport Laboratories by Vaxxinova. Industry incumbents are advancing their competitive stances through portfolio enhancement, ensuring a broadened scope for veterinary applications.
The comprehensive market report details the factors influencing the growth trajectory and provides insights into various vaccine types, including attenuated live, inactivated, subunit, DNA, and recombinant vaccines. The report covers the distribution channels encompassing veterinary hospitals, pharmacies, and the dynamics of direct sales.
Swine Vaccine Market Outlook
- Increased focus on disease prevention and herd health management.
- Technological advancements in vaccine delivery and formulation.
- Expansion of global market due to increased pork consumption and production.
- Commitment of major industry players to innovative solutions for emerging and established swine diseases.
This market report offers a comprehensive understanding of the current situation and future growth potential, providing essential information for stakeholders and industry participants. The analysis delivers a complete perspective on the market, from economic impacts to evolving opportunities in the realm of swine health.
The insights compiled within this report aim to equip the industry with actionable intelligence, fostering informed decision-making and strategy formulation in the global pursuit of enhanced swine health and productivity.
For those attuned to the developments of the animal health industry and the specific challenges and advances within the swine sector, this report provides an invaluable overview of a market that stands as a cornerstone to global food security and agricultural sustainability.
A selection of companies mentioned in this report includes
- Merck & Co Inc.
- Boehringer Ingelheim Animal Health USA Inc.
- Elanco Animal Health Inc.
- Biogenesis Bago SA
- Phibro Animal Health Corporation
- KM Biologics Co. Ltd.
- Hipra Laboratories SA
- Ceva Santé Animale SA
- Zoetis Inc.
- Jinyu Bio-Technology Co. Ltd.
- China Animal Husbandry Industry Co. Ltd.
- Virbac SA
- Harbin Veterinary Research Institute
- Bioveta AS
- Bimeda Holdings PLC
- Biovac Ltd.
- Heska Corporation
- Hester Biosciences Limited
- Hygieia Biological Laboratories
- IDT Biologika GmbH
- Inovio Pharmaceuticals Inc.
- Intervet Inc.
- Komipharm International Co. Ltd.
- Kyoritsu Seiyaku Corporation
- Laboratorios Hipra SA
- Lohmann Animal Health International
- Nexvet Biopharma PLC
- Norbrook Laboratories Limited
- Ouro Fino Saúde Animal SA
- Prondil SA
- Vaxxinova International BV
- Vetoquinol SA
- Veyx Pharma GmbH
- Tianjin Ringpu Bio-Technology Co. Ltd.